COSOPT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug COSOPT contains a combination of these active pharmaceutical ingredients (APIs):

1	Dorzolamide UNII QZO5366EW7 - DORZOLAMIDE HYDROCHLORIDE
	Dorzolamide is a potent inhibitor of human carbonic anhydrase II. Following topical ocular administration, dorzolamide reduces elevated intra-ocular pressure, whether or not associated with glaucoma.
	Read more about Dorzolamide
2	Timolol UNII P8Y54F701R - TIMOLOL MALEATE
	Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.
	Read more about Timolol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
COSOPT Eye drops, solution	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01ED51	Timolol, combinations	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5542Q, 8567X
BR	Câmara de Regulação do Mercado de Medicamentos	556717100001217, 556717100001317
CA	Health Products and Food Branch	02240113, 02258692
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00120336, 00120342, 00572794, 00745622, 01035578, 01035590, 01035615, 03397133, 03404927, 04131199, 04131207, 04131213, 04347278, 04347284, 04347290, 05026211, 05026292, 05026300, 05495414, 05495420, 06434544, 06474733, 06924544, 06964437, 06964466, 09900604, 09900610, 10535995, 10536026, 10993611, 11006425, 11340880, 11340897, 11380081, 11522380, 11557390, 11597432, 11599402, 11613987, 12421936, 12490860, 12490937, 12559221, 14300148, 14300154, 15266324, 16147136, 16503631, 16503648, 16503654, 16617814, 17176683, 17176944, 17176950, 17586381, 17586398, 17669635, 17669664
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	22.583-1-02-06
EE	Ravimiamet	1039799, 1483882, 1741733, 1774324, 1774346
ES	Centro de información online de medicamentos de la AEMPS	3400934806384, 62535, 83389
FI	Lääkealan turvallisuus- ja kehittämiskeskus	061951, 114447, 440064
FR	Base de données publique des médicaments	62782316
GB	Medicines & Healthcare Products Regulatory Agency	109293, 14900, 182248, 198697, 198699, 198735, 365731, 373921, 376271, 378122, 381273, 392396, 393599
HK	Department of Health Drug Office	46578, 65674
HR	Agencija za lijekove i medicinske proizvode	HR-H-149562311, HR-H-438170589
IE	Health Products Regulatory Authority	18510, 18525, 18530, 18533, 73764
IL	מִשְׂרַד הַבְּרִיאוּת	3827
IT	Agenzia del Farmaco	034242103
JP	医薬品医療機器総合機構	1319819Q1020, 1319819Q2026
LT	Valstybinė vaistų kontrolės tarnyba	1003292, 1055301, 1055883, 1057508, 1063170, 1063171, 1068712, 1082390, 1084658, 1084659, 1084660, 1086370, 1086371, 1086372
MT	Medicines Authority	AA1068/00301
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	078M98
NL	Z-Index G-Standaard	14235463
NL	Z-Index G-Standaard, PRK	134155, 134163
PL	Rejestru Produktów Leczniczych	100089391, 100248955, 100389354
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W57438001, W57438002, W57438003, W57438004, W57438005, W57438006, W62674001, W62674002, W65460001, W65460002, W65460003
SG	Health Sciences Authority	11643P, 15435P
TN	Direction de la Pharmacie et du Médicament	18583011, 5963142
US	FDA, National Drug Code	17478-604, 17478-605
ZA	Health Products Regulatory Authority	32/15.4/0525